SHRI PHARMACY GROUP LIMITEDActive

Company number 11519213Private limited companyIncorporated 2018
⚠ Accounts overdue. The next accounts were due on 5 Sep 2026 and had not been filed when the register was last updated.

Key figures

£60,748+623.0%
Net assets 2025
+26.8%
Average annual growth 2020/21–2025
020 k40 k60 k80 k2020/212021/222022/232023/242025

Like most small UK companies, SHRI PHARMACY GROUP LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2020/212021/222022/232023/242025
Filed accounts2020/21–2025
2020/212021/222022/232023/242025
Cash at bank and in hand32,227————
Total assets548,824492,347478,535459,831393,482
Total liabilities525,351477,947473,829451,429454,230
Net assets / total equity23,47314,4004,7068,40260,748
Average number of employees83344

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SHRI PHARMACY GROUP LIMITED

Company

SHRI PHARMACY GROUP LIMITED is a private limited company registered with Companies House under company number 11519213. It was incorporated on 15 Aug 2018. Its status is active. The registered office is in London (NW9). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2025 (period ending 5 Dec 2025); the company files micro-entity accounts. Net assets were £60,748, up 623% on the previous year. Total assets were £393,482 and total liabilities £454,230. The company had an average of 4 employees. Figures are available for 5 financial years (2020/21–2025).

Control and charges

One person with significant control is registered. 3 of 5 registered charges are outstanding.

Filing deadlines

The next accounts are due by 5 Sep 2026. The next confirmation statement is due by 28 Aug 2027.